ResMed (RMD) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $209.63 +4.24%
Revenue Growth %: +13.1%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
CRMT, More
Revenue Growth %: +13.1%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $2.20, $0.15 better than the analyst estimate of $2.05. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.19 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Midera Food Processing and Centrus Energy to join S&P SmallCap 600
- Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
